Anerobe-Mediated Anticancer Gene Therapy - John Brown

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Cancer Institute (NCI)
Type: Research Project (R01)
Project #: 5R01CA064697-07
Application #: 6734628
Study Section: Experimental Therapeutics Subcommittee 1 (ET)
Program Officer: Wolpert, Mary K

Project Start: 1996-09-01
Project End: 2005-05-31
Budget Start: 2004-06-01
Budget End: 2005-05-31
Support Year: 7
Fiscal Year: 2004
Total Cost: $294,734
Indirect Cost

Institution

Name: Stanford University
Department: Radiation-Diagnostic/Oncology
Type: Schools of Medicine
DUNS #: 009214214

City: Stanford
State: CA
Country: United States
Zip Code: 94305

Related projects


NIH 2004 R01 CA	Anerobe-Mediated Anticancer Gene Therapy Brown, John Martin / Stanford University	$294,734
NIH 2003 R01 CA	Anerobe-Mediated Anticancer Gene Therapy Brown, John Martin / Stanford University	$294,673
NIH 2002 R01 CA	Anerobe-Mediated Anticancer Gene Therapy Brown, John Martin / Stanford University	$294,617
NIH 2001 R01 CA	Anerobe-Mediated Anticancer Gene Therapy Brown, John Martin / Stanford University	$297,568
NIH 1998 R01 CA	Anaerobe Mediated Anticancer Gene Therapy Brown, John Martin / Stanford University
NIH 1997 R01 CA	Anaerobe Mediated Anticancer Gene Therapy Brown, John Martin / Stanford University
NIH 1996 R01 CA	Anaerobe Mediated Anticancer Gene Therapy Brown, John Martin / Stanford University

Publications

Brown, J Martin (2002) Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther 1:453-8

Liu, S C; Minton, N P; Giaccia, A J et al. (2002) Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis. Gene Ther 9:291-6

Lemmon, M J; van Zijl, P; Fox, M E et al. (1997) Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment. Gene Ther 4:791-6

Comments

Be the first to comment on this grant